Five Prime Therapeutics, Inc

(NASDAQ:FPRX)

Latest On Five Prime Therapeutics, Inc (FPRX):

Date/Time Type Description Signal Details
2021-04-16 13:31 ESTNewsAmgen completes $1.9B acquisition of Five Prime TherapeuticsN/A
2021-03-13 00:56 ESTNewsFive Prime Is Acquired By Amgen In A Shareholder-Friendly DealN/A
2021-03-09 07:44 ESTAnalyst RatingThe Analyst Target Price has increased from $35.67 to $37.17.Neutral
2021-03-05 07:47 ESTAnalyst RatingThe Analyst Target Price has increased from $27.29 to $35.67.Neutral
2021-03-04 22:25 ESTNewsAmgen to acquire Five Prime Therapeutics for $1.9BN/A
2021-01-22 03:41 ESTAnalyst RatingThe Analyst Target Price has increased from $27.14 to $27.29.Buy
2021-01-16 01:16 ESTNewsFive Prime Therapeutics (FPRX) Presents at ASCO Gastrointestinal Cancer Symposium 2021 - SlideshowN/A
2021-01-15 10:28 ESTNewsFive Prime's bemarituzumab shows PFS benefit in mid-stage gastric cancer studyN/A
2020-12-11 06:04 ESTNewsFive Prime Therapeutics: Understanding BemarituzumabN/A
2020-12-05 04:25 ESTNewsFive Prime Therapeutics: Primed For GrowthN/A
2020-12-01 12:00 ESTAnalyst RatingThe Analyst Target Price has increased from $27 to $27.14.Buy
2020-11-26 20:04 ESTFinancialsCompany financials have been released.Neutral
2020-11-14 03:09 ESTNewsFive Prime prices upsized equity offering at $21N/A
2020-11-12 23:51 ESTNewsFive Prime shares rise 14% as anti-CCR8 antibody FPA157 shows promising effectN/A
2020-11-12 11:46 ESTAnalyst RatingThe Analyst Target Price has increased from $8.5 to $27.Buy
2020-11-11 19:31 ESTNewsFive Prime rockets 210% on bemarituzumab data in gastric cancerN/A
2020-11-11 19:30 ESTNewsFive Prime soars 304% as bemarituzumab + chemo shows significant benefitN/A
2020-11-11 19:27 ESTNewsFive Prime Therapeutics initiates equity raiseN/A
2020-11-07 15:52 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 18:49 ESTInsider TradePARTNERS L P/IL BVF has directly acquired 2,334 shares and currently holds 583,912 shares.Buy
2020-11-06 18:49 ESTInsider TradePARTNERS L P/IL BVF has directly acquired 15,355 shares and currently holds 581,578 shares.Buy
2020-11-06 18:49 ESTInsider TradePARTNERS L P/IL BVF has directly acquired 143,403 shares and currently holds 3,424,554 shares.Buy
2020-11-06 18:49 ESTInsider TradePARTNERS L P/IL BVF has directly acquired 10,436 shares and currently holds 3,434,990 shares.Buy
2020-11-06 18:49 ESTInsider TradePARTNERS L P/IL BVF has directly acquired 17,230 shares and currently holds 4,611,909 shares.Buy
2020-11-06 18:49 ESTInsider TradePARTNERS L P/IL BVF has directly acquired 257,804 shares and currently holds 4,594,679 shares.Buy
2020-11-05 03:50 ESTAnalyst RatingThe Analyst Target Price has decreased from $8.83 to $8.5.Neutral
2020-11-04 19:51 ESTFinancialsCompany financials have been released.Neutral
2020-11-04 07:44 ESTEarnings EstimateAn EPS average of -$0.46 is estimated for the quarter ending on March 31, 2021.Buy
2020-11-04 02:16 ESTNewsFive Prime Therapeutics EPS misses by $0.15, misses on revenueN/A
2020-11-04 02:15 ESTNewsFive Prime Therapeutics, Inc. (FPRX) CEO Tom Civik On Q3 2020 Results - Quick Version Earnings Call TranscriptN/A
2020-11-04 02:15 ESTNewsFive Prime Therapeutics, Inc. (FPRX) CEO Tom Civik on Q3 2020 Results - Earnings Call TranscriptN/A
2020-10-08 17:51 ESTInsider TradePARTNERS L P/IL BVF has directly acquired 25,107 shares and currently holds 566,223 shares.Buy
2020-10-08 17:51 ESTInsider TradePARTNERS L P/IL BVF has directly acquired 162,352 shares and currently holds 3,281,151 shares.Buy
2020-10-08 17:51 ESTInsider TradePARTNERS L P/IL BVF has directly acquired 157,782 shares and currently holds 4,336,875 shares.Buy
2020-09-26 12:48 ESTFinancialsCompany financials have been released.Neutral
2020-09-24 20:20 ESTInsider TradePARTNERS L P/IL BVF has directly acquired 32 shares and currently holds 541,116 shares.Buy
2020-09-23 09:00 ESTAnalyst RatingThe Analyst Target Price has increased from $8.4 to $8.83.Buy
2020-09-17 04:56 ESTFinancialsCompany financials have been released.Neutral
2020-09-12 05:27 ESTNewsFive Prime Therapeutics (FPRX) Presents At Wells Fargo Securities 2020 Virtual Healthcare Conference - SlideshowN/A
2020-08-14 08:52 ESTFinancialsCompany financials have been released.Neutral
2020-08-09 14:05 ESTNewsFive Prime Therapeutics, Inc. (FPRX) CEO Tom Civik on Q2 2020 Results - Earnings Call TranscriptN/A
2020-08-07 20:47 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 17:30 ESTNewsFive Prime Therapeutics EPS beats by $0.22, misses on revenueN/A
2020-07-31 01:02 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 17:04 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 08:46 ESTFinancialsCompany financials have been released.Neutral
2020-07-07 04:43 ESTAnalyst RatingThe Analyst Target Price has increased from $7.6 to $8.4.Buy
2020-06-26 08:45 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 04:48 ESTFinancialsCompany financials have been released.Neutral
2020-06-02 04:50 ESTEarnings EstimateAn EPS average of -$0.62 is estimated for the quarter ending on September 30, 2020.Sell

About Five Prime Therapeutics, Inc (FPRX):

Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of innovative protein therapeutics. The company's product candidates comprise Bemarituzumab, an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, which is in Phase 3 clinical trials to treat patients with gastric or gastroesophageal junction and GEJ cancer; and FPA150, a CD8 T cell checkpoint inhibitor antibody that is in Phase 1a/1b clinical trial that targets B7-H4 in various cancers, as well as FPT155, a soluble CD80 fusion protein, which is in Phase 1a/1b clinical trial that enhances co-stimulation of T cells through CD28. Its product candidates also include Cabiralizumab, an antibody that inhibits colony stimulating factor-1 receptor that is in Phase Ia/Ib clinical trials for the treatment of various cancers in combination with Opdivo. The company's BMS-986258, an anti-T cell immunoglobulin and mucin domain-3 antibody, which is in Phase 1/2 clinical trial as a single agent and in combination with Opdivo in patients with advanced malignant tumors. It has license and collaboration agreements with Bristol-Myers Squibb Company, GlaxoSmithKline LLC, INBRX 110 LP, UCB Pharma S.A., and Zai Lab (Shanghai) Co., Ltd.; and license agreements with Galaxy Biotech, LLC, BioWa, Inc. and Lonza Sales AG. The company was founded in 2001 and is headquartered in South San Francisco, California.

FPRX Quotes by TradingView

See Advanced Chart

General

  • Name Five Prime Therapeutics, Inc
  • Symbol FPRX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 87
  • Fiscal Year EndDecember
  • IPO Date2013-09-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.fiveprime.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 78.32
  • Price/Book (Most Recent Quarter) 18.27
  • Enterprise Value Revenue 97.98
  • Enterprise Value EBITDA 0.03
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.59
  • Operating Margin -513%
  • Return on Assets -26%
  • Return on Equity -69%
  • Revenue 17.1 million
  • Earnings Per Share -$4.49
  • Revenue Per Share $0.48
  • Gross Profit -92976000
  • Quarterly Earnings Growth -31.4%
View More

Highlights

  • Market Capitalization 1.73 billion
  • EBITDA -154670000
  • PEG Ratio 0.14
  • Analyst Target Price $37.17
  • Book Value Per Share $2.67
View More

Share Statistics

  • Shares Outstanding 45.94 million
  • Shares Float 20.78 million
  • % Held by Insiders 319%
  • % Held by Institutions 47.1%
  • Shares Short 2.85 million
  • Shares Short Prior Month 2.58 million
  • Short Ratio 3.24
  • Short % of Float 8%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • Beta 4.47
  • 52 Week High $38.9
  • 52 Week Low $1.95
  • 50 Day Moving Average 25.42
  • 200 Day Moving Average 14.87
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Five Prime Therapeutics, Inc (FPRX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Five Prime Therapeutics, Inc (FPRX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-03$N/A-$0.74-$0.63-17.29%
2020-06-302020-08-06$N/A-$0.48-$0.7031.62%
2020-03-312020-05-07$8.41 million-$0.57-$0.6614.04%
2019-12-312020-02-27$3.21 million-$0.89-$0.9910.2%
2019-09-302019-11-06$2.98 million-$1.03-$0.96-6.79%
2019-06-302019-08-07$3.33 million-$0.99-$0.94-5.04%
2019-03-312019-05-08$5.35 million-$1.02-$1.052.69%
2018-12-312019-02-26$4.03 million-$1.12-$1.3516.78%
2018-09-302018-11-06$5.77 million-$1.37-$1.20-14.04%
2018-06-302018-08-08$7.58 million-$0.99-$1.3928.94%
2018-03-312018-05-08$32.49 million-$0.63-$0.8323.91%
2017-12-312018-02-27$13.22 million-$1.04-$1.4025.55%
2017-09-302017-11-06$8.33 million-$1.54-$1.32-16.6%
2017-06-302017-08-08$7.82 million-$1.58-$1.15-37.77%
2017-03-312017-05-04$10.14 million-$1.21-$0.96-25.73%
2016-12-312017-02-23$8.26 million-$0.73-$0.55-32.32%
2016-09-302016-11-03$6.68 million-$0.72-$0.51-40.6%
2016-06-302016-08-04$9.23 million-$0.49-$0.514.67%
2016-03-312016-05-05$6.52 million-$0.49-$0.7937.99%
2015-12-312016-03-10$363.34 million$10.63$9.6110.62%
2015-09-302015-11-04$5.86 million-$0.93-$0.996.06%
2015-06-302015-08-06$6.32 million-$0.45-$0.44-2.27%
2015-03-312015-05-13$4.29 million-$0.44-$0.5012%
2014-12-312015-03-17$4.65 million-$0.55-$0.10-450%
2014-09-302014-11-10$6.06 million-$0.33-$0.4017.5%
2014-06-302014-08-05$4.98 million-$0.46-$0.27-70.37%
2014-03-312014-05-09$3.55 million-$0.46-$0.05-820%
2013-12-312014-03-25$3.79 million-$0.43-$0.40-7.5%
2013-09-302013-11-12$3.48 million-$2.74-$0.53-416.98%

Five Prime Therapeutics, Inc (FPRX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Five Prime Therapeutics, Inc (FPRX) Chart:

Five Prime Therapeutics, Inc (FPRX) News:

Below you will find a list of latest news for Five Prime Therapeutics, Inc (FPRX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Five Prime Therapeutics, Inc (FPRX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Five Prime Therapeutics, Inc (FPRX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120030871/0001209191-20-030871-index.htm
2019-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1175505/000031506619001608/0000315066-19-001608-index.htm
2019-11-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1175505/000031506619001765/0000315066-19-001765-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1175505/000083423720005295/0000834237-20-005295-index.htm
2019-12-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1175505/000090221919000481/0000902219-19-000481-index.htm
2019-10-02SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1175505/000092189519002489/0000921895-19-002489-index.htm
2019-10-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000092189519002490/0000921895-19-002490-index.htm
2019-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000092189519002534/0000921895-19-002534-index.htm
2019-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000092189519002615/0000921895-19-002615-index.htm
2019-10-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000092189519002645/0000921895-19-002645-index.htm
2019-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000092189519002688/0000921895-19-002688-index.htm
2019-11-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1175505/000092189519002694/0000921895-19-002694-index.htm
2019-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000092189519002887/0000921895-19-002887-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000092189519002964/0000921895-19-002964-index.htm
2019-12-27SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1175505/000092189519003077/0000921895-19-003077-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000092189519003078/0000921895-19-003078-index.htm
2020-05-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000092189520001495/0000921895-20-001495-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000092189520001496/0000921895-20-001496-index.htm
2020-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000092189520002475/0000921895-20-002475-index.htm
2020-10-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1175505/000092189520002573/0000921895-20-002573-index.htm
2020-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000092189520002574/0000921895-20-002574-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000092189520002827/0000921895-20-002827-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1175505/000117266120000843/0001172661-20-000843-index.htm
2019-02-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1175505/000119312519049822/0001193125-19-049822-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519051947/0001193125-19-051947-index.htm
2019-02-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1175505/000119312519055073/0001193125-19-055073-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519062416/0001193125-19-062416-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519078255/0001193125-19-078255-index.htm
2019-04-12PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1175505/000119312519104426/0001193125-19-104426-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1175505/000119312519123576/0001193125-19-123576-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519141408/0001193125-19-141408-index.htm
2019-05-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1175505/000119312519143149/0001193125-19-143149-index.htm
2019-05-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519149407/0001193125-19-149407-index.htm
2019-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519169188/0001193125-19-169188-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519180078/0001193125-19-180078-index.htm
2019-06-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519186002/0001193125-19-186002-index.htm
2019-07-01SC TO-ITender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1175505/000119312519186515/0001193125-19-186515-index.htm
2019-07-31SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1175505/000119312519208678/0001193125-19-208678-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519208686/0001193125-19-208686-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519215351/0001193125-19-215351-index.htm
2019-08-19S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1175505/000119312519224532/0001193125-19-224532-index.htm
2019-08-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1175505/000119312519225355/0001193125-19-225355-index.htm
2019-08-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519226881/0001193125-19-226881-index.htm
2019-09-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519249580/0001193125-19-249580-index.htm
2019-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519265123/0001193125-19-265123-index.htm
2019-10-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519265827/0001193125-19-265827-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519285904/0001193125-19-285904-index.htm
2019-11-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519299849/0001193125-19-299849-index.htm
2019-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312519323506/0001193125-19-323506-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312520005816/0001193125-20-005816-index.htm
2020-01-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312520011034/0001193125-20-011034-index.htm
2020-02-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312520039763/0001193125-20-039763-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312520050063/0001193125-20-050063-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312520052660/0001193125-20-052660-index.htm
2020-04-068-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312520099480/0001193125-20-099480-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312520105938/0001193125-20-105938-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312520110637/0001193125-20-110637-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312520136233/0001193125-20-136233-index.htm
2020-05-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1175505/000119312520136347/0001193125-20-136347-index.htm
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312520147284/0001193125-20-147284-index.htm
2020-08-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1175505/000119312520211945/0001193125-20-211945-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312520211961/0001193125-20-211961-index.htm
2020-09-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312520236633/0001193125-20-236633-index.htm
2020-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312520239206/0001193125-20-239206-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312520284038/0001193125-20-284038-index.htm
2020-11-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1175505/000119312520284779/0001193125-20-284779-index.htm
2019-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119014250/0001209191-19-014250-index.htm
2019-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119014252/0001209191-19-014252-index.htm
2019-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119014255/0001209191-19-014255-index.htm
2019-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119014263/0001209191-19-014263-index.htm
2019-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119014274/0001209191-19-014274-index.htm
2019-02-284/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119014685/0001209191-19-014685-index.htm
2019-03-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119015895/0001209191-19-015895-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119015914/0001209191-19-015914-index.htm
2019-04-044/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119023661/0001209191-19-023661-index.htm
2019-05-023/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119026931/0001209191-19-026931-index.htm
2019-05-023/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119026933/0001209191-19-026933-index.htm
2019-05-023/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119026937/0001209191-19-026937-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119030602/0001209191-19-030602-index.htm
2019-05-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119030606/0001209191-19-030606-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119030613/0001209191-19-030613-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119035716/0001209191-19-035716-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119036497/0001209191-19-036497-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119036502/0001209191-19-036502-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119036504/0001209191-19-036504-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119036506/0001209191-19-036506-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119036508/0001209191-19-036508-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119036510/0001209191-19-036510-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119036513/0001209191-19-036513-index.htm
2019-06-123/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119036524/0001209191-19-036524-index.htm
2019-06-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119038895/0001209191-19-038895-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119038903/0001209191-19-038903-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119039096/0001209191-19-039096-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119039101/0001209191-19-039101-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119039104/0001209191-19-039104-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119039109/0001209191-19-039109-index.htm
2019-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119047176/0001209191-19-047176-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119048073/0001209191-19-048073-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119048074/0001209191-19-048074-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119048075/0001209191-19-048075-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119048076/0001209191-19-048076-index.htm
2019-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119052804/0001209191-19-052804-index.htm
2019-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119053725/0001209191-19-053725-index.htm
2019-11-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119057402/0001209191-19-057402-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119058314/0001209191-19-058314-index.htm
2019-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119059155/0001209191-19-059155-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919119061649/0001209191-19-061649-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120004225/0001209191-20-004225-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120004227/0001209191-20-004227-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120007291/0001209191-20-007291-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120007293/0001209191-20-007293-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120011327/0001209191-20-011327-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120013257/0001209191-20-013257-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120013272/0001209191-20-013272-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120013276/0001209191-20-013276-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120014866/0001209191-20-014866-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120018244/0001209191-20-018244-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120020394/0001209191-20-020394-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120020592/0001209191-20-020592-index.htm
2020-04-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120024361/0001209191-20-024361-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120024363/0001209191-20-024363-index.htm
2020-04-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120025176/0001209191-20-025176-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120029794/0001209191-20-029794-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120029806/0001209191-20-029806-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120029825/0001209191-20-029825-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120029829/0001209191-20-029829-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120029832/0001209191-20-029832-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120029958/0001209191-20-029958-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120030871/0001209191-20-030871-index.htm
2020-08-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120048041/0001209191-20-048041-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1175505/000120919120052976/0001209191-20-052976-index.htm
2019-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1175505/000156459019004472/0001564590-19-004472-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1175505/000156459019018046/0001564590-19-018046-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1175505/000156459019030335/0001564590-19-030335-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1175505/000156459019041128/0001564590-19-041128-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1175505/000156459020007407/0001564590-20-007407-index.htm
2020-04-03DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1175505/000156459020015093/0001564590-20-015093-index.htm
2020-04-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1175505/000156459020017915/0001564590-20-017915-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1175505/000156459020022885/0001564590-20-022885-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1175505/000156459020037792/0001564590-20-037792-index.htm
2020-11-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1175505/000156459020050006/0001564590-20-050006-index.htm
2019-08-22EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1175505/999999999519001944/9999999995-19-001944-index.htm
2019-03-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1175505/999999999719001435/9999999997-19-001435-index.htm
2019-04-03CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1175505/999999999719002314/9999999997-19-002314-index.htm
2019-04-03CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1175505/999999999719002315/9999999997-19-002315-index.htm
2019-08-02CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1175505/999999999719006366/9999999997-19-006366-index.htm
2019-08-02CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1175505/999999999719006367/9999999997-19-006367-index.htm
2019-08-02CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1175505/999999999719006368/9999999997-19-006368-index.htm
2020-02-12SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1175505/999999999720000643/9999999997-20-000643-index.htm
2020-03-03SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1175505/999999999720001107/9999999997-20-001107-index.htm
2020-08-03CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1175505/999999999720004259/9999999997-20-004259-index.htm
2020-08-05CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1175505/999999999720004282/9999999997-20-004282-index.htm

Five Prime Therapeutics, Inc (FPRX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Five Prime Therapeutics, Inc (FPRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 319%
Institutional Ownership: 4710%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-02-24Francis Willard SarenaChief Strategy OfficerBuy15,000.00108,178.00https://www.sec.gov/Archives/edgar/data/1175505/000120919120013276/0001209191-20-013276-index.htm
2019-02-28David WhiteOfficerBuy15,000.0015,000.00https://www.sec.gov/Archives/edgar/data/1175505/000120919119015914/0001209191-19-015914-index.htm
2019-10-04PARTNERS L P/IL BVF10% Share HolderBuy7,314.003.7427,336.081,669,588.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002534/0000921895-19-002534-index.htm
2019-10-07PARTNERS L P/IL BVF10% Share HolderBuy80,821.003.75302,933.271,750,409.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002534/0000921895-19-002534-index.htm
2019-10-07PARTNERS L P/IL BVF10% Share HolderBuy138,609.003.75519,783.751,889,018.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002534/0000921895-19-002534-index.htm
2019-10-08PARTNERS L P/IL BVF10% Share HolderBuy24,716.003.6891,029.031,913,734.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002534/0000921895-19-002534-index.htm
2019-06-07Aron Marc KnickerbockerPresident & CEOBuy11,357.005.5462,917.78195,828.00https://www.sec.gov/Archives/edgar/data/1175505/000120919119035716/0001209191-19-035716-index.htm
2019-10-24PARTNERS L P/IL BVF10% Share HolderBuy57,723.003.74216,155.321,971,457.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002615/0000921895-19-002615-index.htm
2019-10-25PARTNERS L P/IL BVF10% Share HolderBuy12,899.003.7548,336.421,984,356.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002615/0000921895-19-002615-index.htm
2019-10-29PARTNERS L P/IL BVF10% Share HolderBuy1,133.003.904,415.191,985,489.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002645/0000921895-19-002645-index.htm
2019-10-30PARTNERS L P/IL BVF10% Share HolderBuy8,236.003.8932,055.341,993,725.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002645/0000921895-19-002645-index.htm
2019-10-31PARTNERS L P/IL BVF10% Share HolderBuy2,913.003.8511,213.881,996,638.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002645/0000921895-19-002645-index.htm
2019-10-04PARTNERS L P/IL BVF10% Share HolderBuy7,695.003.7428,760.062,054,006.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002534/0000921895-19-002534-index.htm
2019-10-07PARTNERS L P/IL BVF10% Share HolderBuy98,333.003.75368,571.752,152,339.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002534/0000921895-19-002534-index.htm
2019-02-25Aron Marc KnickerbockerPresident & CEOBuy25,844.00220,907.00https://www.sec.gov/Archives/edgar/data/1175505/000120919119014274/0001209191-19-014274-index.htm
2019-10-07PARTNERS L P/IL BVF10% Share HolderBuy168,640.003.75632,400.002,320,979.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002534/0000921895-19-002534-index.htm
2019-10-08PARTNERS L P/IL BVF10% Share HolderBuy31,007.003.68114,198.782,351,986.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002534/0000921895-19-002534-index.htm
2019-10-23PARTNERS L P/IL BVF10% Share HolderBuy3,200.003.7511,985.602,355,186.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002615/0000921895-19-002615-index.htm
2019-11-05PARTNERS L P/IL BVF10% Share HolderBuy400,470.004.001,601,880.002,397,108.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002688/0000921895-19-002688-index.htm
2019-10-24PARTNERS L P/IL BVF10% Share HolderBuy76,036.003.74284,732.012,431,222.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002615/0000921895-19-002615-index.htm
2019-10-25PARTNERS L P/IL BVF10% Share HolderBuy15,728.003.7558,937.532,446,950.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002615/0000921895-19-002615-index.htm
2019-10-29PARTNERS L P/IL BVF10% Share HolderBuy1,027.003.904,002.122,447,977.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002645/0000921895-19-002645-index.htm
2019-10-30PARTNERS L P/IL BVF10% Share HolderBuy10,389.003.8940,435.032,458,366.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002645/0000921895-19-002645-index.htm
2019-10-31PARTNERS L P/IL BVF10% Share HolderBuy3,416.003.8513,150.232,461,782.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002645/0000921895-19-002645-index.htm
2019-11-22PARTNERS L P/IL BVF10% Share HolderBuy462,056.003.401,571,036.612,859,164.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002887/0000921895-19-002887-index.htm
2019-12-09PARTNERS L P/IL BVF10% Share HolderBuy18,729.004.0275,243.762,877,893.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002964/0000921895-19-002964-index.htm
2019-11-05PARTNERS L P/IL BVF10% Share HolderBuy496,721.004.001,986,884.002,958,503.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002688/0000921895-19-002688-index.htm
2019-10-04PARTNERS L P/IL BVF10% Share HolderBuy991.003.743,703.86299,487.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002534/0000921895-19-002534-index.htm
2019-12-20PARTNERS L P/IL BVF10% Share HolderBuy201,096.004.05814,438.803,078,989.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519003078/0000921895-19-003078-index.htm
2020-05-14PARTNERS L P/IL BVF10% Share HolderBuy39,810.004.10163,221.003,118,799.00https://www.sec.gov/Archives/edgar/data/1175505/000092189520001496/0000921895-20-001496-index.htm
2019-10-07PARTNERS L P/IL BVF10% Share HolderBuy14,242.003.7553,381.86313,729.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002534/0000921895-19-002534-index.htm
2019-02-25Bryan IrvingEVP, Chief Scientific OfficerBuy10,000.0032,271.00https://www.sec.gov/Archives/edgar/data/1175505/000120919119014263/0001209191-19-014263-index.htm
2020-10-06PARTNERS L P/IL BVF10% Share HolderBuy162,352.005.04817,442.323,281,151.00https://www.sec.gov/Archives/edgar/data/1175505/000092189520002574/0000921895-20-002574-index.htm
2019-10-07PARTNERS L P/IL BVF10% Share HolderBuy24,425.003.7591,593.75338,154.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002534/0000921895-19-002534-index.htm
2020-11-04PARTNERS L P/IL BVF10% Share HolderBuy143,403.004.88700,408.933,424,554.00https://www.sec.gov/Archives/edgar/data/1175505/000092189520002827/0000921895-20-002827-index.htm
2019-10-08PARTNERS L P/IL BVF10% Share HolderBuy4,689.003.6817,269.59342,843.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002534/0000921895-19-002534-index.htm
2020-11-06PARTNERS L P/IL BVF10% Share HolderBuy10,436.004.9852,013.023,434,990.00https://www.sec.gov/Archives/edgar/data/1175505/000092189520002827/0000921895-20-002827-index.htm
2019-10-24PARTNERS L P/IL BVF10% Share HolderBuy1,629.003.746,100.12344,472.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002615/0000921895-19-002615-index.htm
2019-10-25PARTNERS L P/IL BVF10% Share HolderBuy2,155.003.758,075.43346,627.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002615/0000921895-19-002615-index.htm
2019-10-29PARTNERS L P/IL BVF10% Share HolderBuy240.003.90935.26346,867.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002645/0000921895-19-002645-index.htm
2019-10-30PARTNERS L P/IL BVF10% Share HolderBuy1,456.003.895,666.90348,323.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002645/0000921895-19-002645-index.htm
2019-10-31PARTNERS L P/IL BVF10% Share HolderBuy504.003.851,940.20348,827.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002645/0000921895-19-002645-index.htm
2020-01-20David WhiteOfficerBuy20,000.0035,000.00https://www.sec.gov/Archives/edgar/data/1175505/000120919120013257/0001209191-20-013257-index.htm
2019-11-22PARTNERS L P/IL BVF10% Share HolderBuy576,097.003.401,958,787.413,534,600.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002887/0000921895-19-002887-index.htm
2019-12-09PARTNERS L P/IL BVF10% Share HolderBuy113,874.004.02457,488.803,648,474.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002964/0000921895-19-002964-index.htm
2019-12-20PARTNERS L P/IL BVF10% Share HolderBuy281,318.004.051,139,337.903,929,792.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519003078/0000921895-19-003078-index.htm
2019-02-25Helen Louise CollinsSVP and Chief Medical OfficerBuy10,000.0040,971.00https://www.sec.gov/Archives/edgar/data/1175505/000120919119014255/0001209191-19-014255-index.htm
2020-05-14PARTNERS L P/IL BVF10% Share HolderBuy249,301.004.101,022,134.104,179,093.00https://www.sec.gov/Archives/edgar/data/1175505/000092189520001496/0000921895-20-001496-index.htm
2019-11-05PARTNERS L P/IL BVF10% Share HolderBuy70,921.004.00283,684.00419,748.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002688/0000921895-19-002688-index.htm
2020-10-06PARTNERS L P/IL BVF10% Share HolderBuy157,782.005.04794,432.374,336,875.00https://www.sec.gov/Archives/edgar/data/1175505/000092189520002574/0000921895-20-002574-index.htm
2019-08-20Helen Louise CollinsEVP and Chief Medical OfficerBuy5,000.0044,794.00https://www.sec.gov/Archives/edgar/data/1175505/000120919119047176/0001209191-19-047176-index.htm
2020-02-24David WhiteOfficerBuy10,000.0045,000.00https://www.sec.gov/Archives/edgar/data/1175505/000120919120013257/0001209191-20-013257-index.htm
2020-11-04PARTNERS L P/IL BVF10% Share HolderBuy257,804.004.881,259,166.304,594,679.00https://www.sec.gov/Archives/edgar/data/1175505/000092189520002827/0000921895-20-002827-index.htm
2020-11-06PARTNERS L P/IL BVF10% Share HolderBuy17,230.004.9885,874.324,611,909.00https://www.sec.gov/Archives/edgar/data/1175505/000092189520002827/0000921895-20-002827-index.htm
2020-02-24David V SmithExecutive Vice President & CFOBuy15,000.0048,389.00https://www.sec.gov/Archives/edgar/data/1175505/000120919120018244/0001209191-20-018244-index.htm
2019-12-03FRANKLIN M BERGERDirectorSell47,890.004.00191,560.005,000.00https://www.sec.gov/Archives/edgar/data/1175505/000120919119059155/0001209191-19-059155-index.htm
2019-11-22PARTNERS L P/IL BVF10% Share HolderBuy81,857.003.40278,321.99501,605.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002887/0000921895-19-002887-index.htm
2019-12-09PARTNERS L P/IL BVF10% Share HolderBuy2,397.004.029,629.95504,002.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519002964/0000921895-19-002964-index.htm
2019-12-02FRANKLIN M BERGERDirectorSell32,090.003.92125,792.8052,890.00https://www.sec.gov/Archives/edgar/data/1175505/000120919119059155/0001209191-19-059155-index.htm
2019-12-20PARTNERS L P/IL BVF10% Share HolderBuy32,606.004.05132,054.30536,608.00https://www.sec.gov/Archives/edgar/data/1175505/000092189519003078/0000921895-19-003078-index.htm
2020-02-24Helen Louise CollinsEVP and Chief Medical OfficerBuy15,000.0053,953.00https://www.sec.gov/Archives/edgar/data/1175505/000120919120013272/0001209191-20-013272-index.htm
2020-05-14PARTNERS L P/IL BVF10% Share HolderBuy4,476.004.1018,351.60541,084.00https://www.sec.gov/Archives/edgar/data/1175505/000092189520001496/0000921895-20-001496-index.htm
2020-09-22PARTNERS L P/IL BVF10% Share HolderBuy32.003.80121.56541,116.00https://www.sec.gov/Archives/edgar/data/1175505/000092189520002475/0000921895-20-002475-index.htm
2020-10-06PARTNERS L P/IL BVF10% Share HolderBuy25,107.005.04126,413.75566,223.00https://www.sec.gov/Archives/edgar/data/1175505/000092189520002574/0000921895-20-002574-index.htm
2020-11-04PARTNERS L P/IL BVF10% Share HolderBuy15,355.004.8874,996.89581,578.00https://www.sec.gov/Archives/edgar/data/1175505/000092189520002827/0000921895-20-002827-index.htm
2020-11-06PARTNERS L P/IL BVF10% Share HolderBuy2,334.004.9811,632.66583,912.00https://www.sec.gov/Archives/edgar/data/1175505/000092189520002827/0000921895-20-002827-index.htm
2020-02-24David V SmithExecutive Vice President & CFOBuy15,000.0063,389.00https://www.sec.gov/Archives/edgar/data/1175505/000120919120018244/0001209191-20-018244-index.htm
2020-02-24Helen Louise CollinsEVP and Chief Medical OfficerBuy15,000.0068,953.00https://www.sec.gov/Archives/edgar/data/1175505/000120919120013272/0001209191-20-013272-index.htm
2020-04-13Thomas CivikPresident and CEOBuy75,000.0075,000.00https://www.sec.gov/Archives/edgar/data/1175505/000120919120024363/0001209191-20-024363-index.htm
2019-02-25Francis Willard SarenaChief Strategy OfficerBuy10,000.0084,149.00https://www.sec.gov/Archives/edgar/data/1175505/000120919119014252/0001209191-19-014252-index.htm
2020-02-24Francis Willard SarenaChief Strategy OfficerBuy15,000.0093,178.00https://www.sec.gov/Archives/edgar/data/1175505/000120919120013276/0001209191-20-013276-index.htm